Which has higher valuation and earnings, GL or PLMR?

Globe Life has higher revenue and earnings than Palomar. Globe Life is trading at a lower price-to-earnings ratio than Palomar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Globe Life $5.99B 2.39 $1.16B $14.46 12.76 Palomar $875.97M 4.18 $197.07M $7.18 19.22

Is GL or PLMR more profitable?

Palomar has a net margin of 20.11% compared to Globe Life's net margin of 19.38%. Palomar's return on equity of 22.62% beat Globe Life's return on equity. Company Net Margins Return on Equity Return on Assets Globe Life 19.38% 20.94% 3.97% Palomar 20.11% 22.62% 6.60%

Does the media favor GL or PLMR?

In the previous week, Globe Life had 5 more articles in the media than Palomar. MarketBeat recorded 10 mentions for Globe Life and 5 mentions for Palomar. Palomar's average media sentiment score of 1.16 beat Globe Life's score of 0.57 indicating that Palomar is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Globe Life 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Palomar 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CRBG or PLMR?

In the previous week, Corebridge Financial had 2 more articles in the media than Palomar. MarketBeat recorded 7 mentions for Corebridge Financial and 5 mentions for Palomar. Palomar's average media sentiment score of 1.16 beat Corebridge Financial's score of 0.71 indicating that Palomar is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Corebridge Financial 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Palomar 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, PLMR or EQH?

Palomar has higher earnings, but lower revenue than Equitable. Equitable is trading at a lower price-to-earnings ratio than Palomar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Palomar $875.97M 4.18 $197.07M $7.18 19.22 Equitable $11.67B 1.13 -$1.38B -$2.84 N/A

Is PLMR or EQH more profitable?

Palomar has a net margin of 20.11% compared to Equitable's net margin of -7.26%. Equitable's return on equity of 232.29% beat Palomar's return on equity. Company Net Margins Return on Equity Return on Assets Palomar 20.11% 22.62% 6.60% Equitable -7.26% 232.29% 0.58%

Does the media favor PLMR or EQH?

In the previous week, Equitable had 3 more articles in the media than Palomar. MarketBeat recorded 8 mentions for Equitable and 5 mentions for Palomar. Equitable's average media sentiment score of 1.23 beat Palomar's score of 1.16 indicating that Equitable is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Palomar 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Equitable 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, RYAN or PLMR?

Palomar has lower revenue, but higher earnings than Ryan Specialty. Palomar is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ryan Specialty $3.05B 3.53 $63.40M $0.77 53.11 Palomar $875.97M 4.18 $197.07M $7.18 19.22

Is RYAN or PLMR more profitable?

Palomar has a net margin of 20.11% compared to Ryan Specialty's net margin of 8.21%. Ryan Specialty's return on equity of 41.33% beat Palomar's return on equity. Company Net Margins Return on Equity Return on Assets Ryan Specialty 8.21% 41.33% 4.80% Palomar 20.11% 22.62% 6.60%

Does the media refer more to RYAN or PLMR?

In the previous week, Palomar had 2 more articles in the media than Ryan Specialty. MarketBeat recorded 5 mentions for Palomar and 3 mentions for Ryan Specialty. Palomar's average media sentiment score of 1.16 beat Ryan Specialty's score of 1.02 indicating that Palomar is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ryan Specialty 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Palomar 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, OSCR or PLMR?

Palomar has lower revenue, but higher earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Palomar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Oscar Health $11.70B 0.79 -$443.15M -$0.59 N/A Palomar $875.97M 4.18 $197.07M $7.18 19.22

Is OSCR or PLMR more profitable?

Palomar has a net margin of 20.11% compared to Oscar Health's net margin of -0.30%. Palomar's return on equity of 22.62% beat Oscar Health's return on equity. Company Net Margins Return on Equity Return on Assets Oscar Health -0.30% -3.26% -0.57% Palomar 20.11% 22.62% 6.60%

Does the media favor OSCR or PLMR?

In the previous week, Palomar had 1 more articles in the media than Oscar Health. MarketBeat recorded 5 mentions for Palomar and 4 mentions for Oscar Health. Palomar's average media sentiment score of 1.16 beat Oscar Health's score of 0.26 indicating that Palomar is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oscar Health 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Palomar 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Palomar (PLMR) Competitors

$138.01 -2.11 (-1.51%)

As of 12:15 PM Eastern

Compare

PLMR vs. GL, CRBG, EQH, RYAN, and OSCR

Should you buy Palomar stock or one of its competitors? MarketBeat compares Palomar with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Palomar include Globe Life (GL), Corebridge Financial (CRBG), Equitable (EQH), Ryan Specialty (RYAN), and Oscar Health (OSCR). These companies are all part of the "insurance" industry.

How does Palomar compare to Globe Life?

Globe Life (NYSE:GL) and Palomar (NASDAQ:PLMR) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

Globe Life presently has a consensus target price of $186.60, indicating a potential upside of 1.17%. Palomar has a consensus target price of $162.50, indicating a potential upside of 17.75%. Given Palomar's higher probable upside, analysts clearly believe Palomar is more favorable than Globe Life.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globe Life	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83
Palomar	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Globe Life has higher revenue and earnings than Palomar. Globe Life is trading at a lower price-to-earnings ratio than Palomar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globe Life	$5.99B	2.39	$1.16B	$14.46	12.76
Palomar	$875.97M	4.18	$197.07M	$7.18	19.22

In the previous week, Globe Life had 5 more articles in the media than Palomar. MarketBeat recorded 10 mentions for Globe Life and 5 mentions for Palomar. Palomar's average media sentiment score of 1.16 beat Globe Life's score of 0.57 indicating that Palomar is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Globe Life	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Palomar	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Palomar has a net margin of 20.11% compared to Globe Life's net margin of 19.38%. Palomar's return on equity of 22.62% beat Globe Life's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Globe Life	19.38%	20.94%	3.97%
Palomar	20.11%	22.62%	6.60%

Globe Life has a beta of 0.47, meaning that its stock price is 53% less volatile than the broader market. Comparatively, Palomar has a beta of 0.41, meaning that its stock price is 59% less volatile than the broader market.

81.6% of Globe Life shares are owned by institutional investors. Comparatively, 90.3% of Palomar shares are owned by institutional investors. 2.1% of Globe Life shares are owned by insiders. Comparatively, 3.7% of Palomar shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Palomar beats Globe Life on 9 of the 17 factors compared between the two stocks.

How does Palomar compare to Corebridge Financial?

Corebridge Financial (NYSE:CRBG) and Palomar (NASDAQ:PLMR) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

Corebridge Financial has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market. Comparatively, Palomar has a beta of 0.41, suggesting that its stock price is 59% less volatile than the broader market.

Palomar has a net margin of 20.11% compared to Corebridge Financial's net margin of 1.20%. Palomar's return on equity of 22.62% beat Corebridge Financial's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Corebridge Financial	1.20%	18.44%	0.59%
Palomar	20.11%	22.62%	6.60%

In the previous week, Corebridge Financial had 2 more articles in the media than Palomar. MarketBeat recorded 7 mentions for Corebridge Financial and 5 mentions for Palomar. Palomar's average media sentiment score of 1.16 beat Corebridge Financial's score of 0.71 indicating that Palomar is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Corebridge Financial	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Palomar	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

98.3% of Corebridge Financial shares are held by institutional investors. Comparatively, 90.3% of Palomar shares are held by institutional investors. 0.3% of Corebridge Financial shares are held by company insiders. Comparatively, 3.7% of Palomar shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Corebridge Financial presently has a consensus target price of $36.50, suggesting a potential upside of 16.35%. Palomar has a consensus target price of $162.50, suggesting a potential upside of 17.75%. Given Palomar's stronger consensus rating and higher possible upside, analysts clearly believe Palomar is more favorable than Corebridge Financial.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Corebridge Financial	0 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.60
Palomar	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Palomar has lower revenue, but higher earnings than Corebridge Financial. Palomar is trading at a lower price-to-earnings ratio than Corebridge Financial, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Corebridge Financial	$20.46B	0.68	-$366M	$0.55	57.04
Palomar	$875.97M	4.18	$197.07M	$7.18	19.22

Summary

Palomar beats Corebridge Financial on 10 of the 16 factors compared between the two stocks.

How does Palomar compare to Equitable?

Palomar (NASDAQ:PLMR) and Equitable (NYSE:EQH) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

In the previous week, Equitable had 3 more articles in the media than Palomar. MarketBeat recorded 8 mentions for Equitable and 5 mentions for Palomar. Equitable's average media sentiment score of 1.23 beat Palomar's score of 1.16 indicating that Equitable is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Palomar	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Equitable	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

90.3% of Palomar shares are owned by institutional investors. Comparatively, 92.7% of Equitable shares are owned by institutional investors. 3.7% of Palomar shares are owned by insiders. Comparatively, 1.1% of Equitable shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Palomar has a net margin of 20.11% compared to Equitable's net margin of -7.26%. Equitable's return on equity of 232.29% beat Palomar's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Palomar	20.11%	22.62%	6.60%
Equitable	-7.26%	232.29%	0.58%

Palomar currently has a consensus price target of $162.50, indicating a potential upside of 17.75%. Equitable has a consensus price target of $60.08, indicating a potential upside of 24.45%. Given Equitable's stronger consensus rating and higher probable upside, analysts plainly believe Equitable is more favorable than Palomar.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Palomar	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Equitable	0 Sell rating(s)	3 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.86

Palomar has higher earnings, but lower revenue than Equitable. Equitable is trading at a lower price-to-earnings ratio than Palomar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Palomar	$875.97M	4.18	$197.07M	$7.18	19.22
Equitable	$11.67B	1.13	-$1.38B	-$2.84	N/A

Palomar has a beta of 0.41, indicating that its share price is 59% less volatile than the broader market. Comparatively, Equitable has a beta of 1.1, indicating that its share price is 10% more volatile than the broader market.

Summary

Equitable beats Palomar on 10 of the 17 factors compared between the two stocks.

How does Palomar compare to Ryan Specialty?

Ryan Specialty (NYSE:RYAN) and Palomar (NASDAQ:PLMR) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

Palomar has lower revenue, but higher earnings than Ryan Specialty. Palomar is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ryan Specialty	$3.05B	3.53	$63.40M	$0.77	53.11
Palomar	$875.97M	4.18	$197.07M	$7.18	19.22

In the previous week, Palomar had 2 more articles in the media than Ryan Specialty. MarketBeat recorded 5 mentions for Palomar and 3 mentions for Ryan Specialty. Palomar's average media sentiment score of 1.16 beat Ryan Specialty's score of 1.02 indicating that Palomar is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ryan Specialty	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Palomar	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Ryan Specialty currently has a consensus target price of $50.00, suggesting a potential upside of 22.27%. Palomar has a consensus target price of $162.50, suggesting a potential upside of 17.75%. Given Ryan Specialty's higher probable upside, analysts clearly believe Ryan Specialty is more favorable than Palomar.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ryan Specialty	2 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.32
Palomar	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Palomar has a net margin of 20.11% compared to Ryan Specialty's net margin of 8.21%. Ryan Specialty's return on equity of 41.33% beat Palomar's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ryan Specialty	8.21%	41.33%	4.80%
Palomar	20.11%	22.62%	6.60%

Ryan Specialty has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market. Comparatively, Palomar has a beta of 0.41, indicating that its share price is 59% less volatile than the broader market.

84.8% of Ryan Specialty shares are held by institutional investors. Comparatively, 90.3% of Palomar shares are held by institutional investors. 52.0% of Ryan Specialty shares are held by insiders. Comparatively, 3.7% of Palomar shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Palomar beats Ryan Specialty on 9 of the 16 factors compared between the two stocks.

How does Palomar compare to Oscar Health?

Oscar Health (NYSE:OSCR) and Palomar (NASDAQ:PLMR) are both mid-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

Palomar has a net margin of 20.11% compared to Oscar Health's net margin of -0.30%. Palomar's return on equity of 22.62% beat Oscar Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oscar Health	-0.30%	-3.26%	-0.57%
Palomar	20.11%	22.62%	6.60%

Oscar Health presently has a consensus price target of $20.78, indicating a potential downside of 31.83%. Palomar has a consensus price target of $162.50, indicating a potential upside of 17.75%. Given Palomar's stronger consensus rating and higher possible upside, analysts clearly believe Palomar is more favorable than Oscar Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oscar Health	1 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.33
Palomar	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

In the previous week, Palomar had 1 more articles in the media than Oscar Health. MarketBeat recorded 5 mentions for Palomar and 4 mentions for Oscar Health. Palomar's average media sentiment score of 1.16 beat Oscar Health's score of 0.26 indicating that Palomar is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oscar Health	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Palomar	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

75.7% of Oscar Health shares are held by institutional investors. Comparatively, 90.3% of Palomar shares are held by institutional investors. 22.6% of Oscar Health shares are held by insiders. Comparatively, 3.7% of Palomar shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Palomar has lower revenue, but higher earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Palomar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oscar Health	$11.70B	0.79	-$443.15M	-$0.59	N/A
Palomar	$875.97M	4.18	$197.07M	$7.18	19.22

Oscar Health has a beta of 2.34, indicating that its share price is 134% more volatile than the broader market. Comparatively, Palomar has a beta of 0.41, indicating that its share price is 59% less volatile than the broader market.

Summary

Palomar beats Oscar Health on 13 of the 17 factors compared between the two stocks.

Get Palomar News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PLMR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PLMR vs. The Competition

Export

Metric	Palomar	INS Industry	Finance Sector	NASDAQ Exchange
Market Cap	$3.64B	$59.93B	$14.38B	$12.42B
Dividend Yield	N/A	1.77%	5.67%	9.39%
P/E Ratio	19.16	11.51	20.56	24.17
Price / Sales	4.18	1.77	45.05	92.83
Price / Cash	17.42	13.37	19.24	47.25
Price / Book	3.88	2.12	2.27	6.23
Net Income	$197.07M	$4.24B	$1.14B	$331.42M
7 Day Performance	1.43%	-0.96%	0.39%	-1.22%
1 Month Performance	23.55%	6.57%	1.54%	-1.36%
1 Year Performance	-1.32%	16.33%	13.41%	18.43%

Palomar Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PLMR Palomar	4.3457 of 5 stars	$138.01 -1.5%	$162.50 +17.7%	+0.4%	$3.64B	$875.97M	19.16	150	Analyst Forecast
GL Globe Life	4.0622 of 5 stars	$178.54 -0.3%	$182.10 +2.0%	+51.0%	$13.91B	$5.99B	12.35	3,695	Upcoming Earnings Analyst Forecast
CRBG Corebridge Financial	4.7288 of 5 stars	$30.85 +1.0%	$36.08 +17.0%	-11.3%	$13.62B	$20.46B	56.08	4,800
EQH Equitable	4.9851 of 5 stars	$47.82 +1.8%	$60.08 +25.6%	-9.0%	$12.83B	$11.67B	N/A	8,000	Positive News
RYAN Ryan Specialty	4.9062 of 5 stars	$41.77 +3.4%	$48.35 +15.8%	-36.5%	$10.65B	$3.05B	54.25	6,110	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PLMR) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Palomar (PLMR) Competitors

PLMR vs. GL, CRBG, EQH, RYAN, and OSCR

How does Palomar compare to Globe Life?

Summary

How does Palomar compare to Corebridge Financial?

Summary

How does Palomar compare to Equitable?

Summary

How does Palomar compare to Ryan Specialty?

Summary

How does Palomar compare to Oscar Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PLMR vs. The Competition

Palomar Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Palomar (PLMR) Competitors

PLMR vs. GL, CRBG, EQH, RYAN, and OSCR

How does Palomar compare to Globe Life?

Do analysts rate GL or PLMR?

Which has higher valuation and earnings, GL or PLMR?

Does the media favor GL or PLMR?

Is GL or PLMR more profitable?

Which has more risk & volatility, GL or PLMR?

Do insiders & institutionals have more ownership in GL or PLMR?

Summary

How does Palomar compare to Corebridge Financial?

Which has more volatility and risk, CRBG or PLMR?

Is CRBG or PLMR more profitable?

Does the media favor CRBG or PLMR?

Do institutionals and insiders hold more shares of CRBG or PLMR?

Do analysts recommend CRBG or PLMR?

Which has higher earnings & valuation, CRBG or PLMR?

Summary

How does Palomar compare to Equitable?

Does the media favor PLMR or EQH?

Do institutionals and insiders have more ownership in PLMR or EQH?

Is PLMR or EQH more profitable?

Do analysts recommend PLMR or EQH?

Which has stronger earnings & valuation, PLMR or EQH?

Which has more risk & volatility, PLMR or EQH?

Summary

How does Palomar compare to Ryan Specialty?

Which has higher valuation & earnings, RYAN or PLMR?

Does the media refer more to RYAN or PLMR?

Do analysts rate RYAN or PLMR?

Is RYAN or PLMR more profitable?

Which has more volatility and risk, RYAN or PLMR?

Do insiders and institutionals hold more shares of RYAN or PLMR?

Summary

How does Palomar compare to Oscar Health?

Is OSCR or PLMR more profitable?

Do analysts recommend OSCR or PLMR?

Does the media favor OSCR or PLMR?

Do insiders & institutionals hold more shares of OSCR or PLMR?

Which has better valuation and earnings, OSCR or PLMR?

Which has more risk & volatility, OSCR or PLMR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PLMR vs. The Competition

Palomar Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools